 So I'm Caroline van Osse, I'm part of the medicine quality research group headed by Paul Newton, who is my supervisor together with Celine Kaia and Ben Sartorius. And I'm looking at the epidemiology of diverted, substandard and false fight medical products and the lessons we can take away from the pandemic. At the very start of the pandemic Paul already was warning us that there would be a risk of increased presence of substance and false fight medical products. And early on with our team we started to produce monthly reports on the presence of these poor quality medical products in our markets. They were very descriptive in nature and as you see for example the map all the countries countries in orange have had alerts on substandard or false fight COVID-19 vaccines during the pandemic. On my default project I want to go a step further and use temporal analysis, spatial temporal analysis, analysis techniques, because our hypothesis is really that there is a pattern in the presence of poor quality medical products in time of locations in the world but also in terms of timing over the course of the pandemic. So medical products or surveillance of this type of product is very core limit in most countries and if there is data available it's rarely published in accessible databases and fairly and rarely in scientific journals. But with the medicine quality research group we try to facilitate access to evidence in general and we have multiple tools but one of them was introduced to you by Alberto, which is our medicine quality monitoring globe. It contains online news media reports really newspapers, but because of the uncertainty of this problem. The extent of the problem of substandard and false fight medical product is uncertain and research is really neglected. We believe that there is an added value in using open source data to have to increase the quality and the quantity of the data and to improve our understanding of the global scale and risk that these type of products can bring along. So currently I'm doing a scoping review looking at the challenges and the limitations but also at the advantages that come with using this type of data as data source for research. So it's really during this time of global emergencies like we had with the pandemic that we believe it's important to have timely analysis of information to illuminate trends and emerging incidences in order to to put in interventions in place. And finally, for my default projects, I will be looking at what the policy implications of these findings are to inform strategies for the better preparedness of the detection the prevent the prevention and the response to poor quality medical products. Thank you all.